InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Greenlees Sharon. Director active across 1 company, notably Bristol Myers Squibb Co. Cumulatively, 1 filings have been logged. History available since 2 May 2023. The latest transaction was filed on 2 May 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration